Autolus Limited Company
Autolus is a leader in T-cell programming and manufacturing technology.
Industry:
Genomic and Epigenominc Instabillity
Investment Stage:
N/A
Technology:
Cell Therapies
Headquarters:
United Kingdom
Founded Date:
2014
Investor Type:
N/A
Funding Status:
IPO
Number Of Exists:
N/A
Employee Number:
11-50